Opens in a new tab or window Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel small molecule thyroid hormone receptor ...
A seaside cape, once called home by the author of the hit novel that inspired the television series "M*A*S*H," is on the ...
Altimmune ALT is developing its lead candidate, pemvidutide, a novel, investigational and peptide-based GLP-1/glucagon dual ...
Sagimet Biosciences, Inc. Class A ( (SGMT) ) has released its Q3 earnings. Here is a breakdown of the information Sagimet Biosciences, Inc.
Safety and Efficacy of the Novel Non-bile Acid FXR Agonist FXR314 in Patients with Metabolic Dysfunction-Associated Steatohepatitis: Results from a Phase 2 Study” was presented on Sunday, November 17 ...